1. Show article details.

    ICON Releases Environmental, Social and Governance Report

    Business Wire – 8:00 AM ET 11/22/2021

    The report looks to the future of ESG for the new ICON while highlighting advancements made in 2020 ICON plc (ICLR) announced today the release of its 2020 Environmental, Social and Governance Report. The ESG Report is available at: https://www.iconplc.com/about/esg/ “As a combined company, new ICON is focused on continuing to develop its ESG strategy and initiatives,” said ICON CEO Steve Cutler.

  2. Show article details.

    BRIEF-Icon PLC Says Accellacare Site Network Expands Reach Through Partnerships With Six Research Sites

    Reuters – 4:47 PM ET 11/10/2021

    ICON PLC (ICLR): * ICON PLC (ICLR) - ACCELLACARE SITE NETWORK HAS EXPANDED IN REACH THROUGH NEW PARTNERSHIPS WITH SIX RESEARCH SITES ACROSS FOUR COUNTRIES Source text for Eikon: Further company coverage:

  3. Show article details.

    ICON Announces the Expansion of its Accellacare Site Network

    Business Wire – 4:02 PM ET 11/10/2021

    New partnerships increase geographical footprint, supporting more access to patients and strengthening therapeutic capability ICON plc (ICLR), a global provider of drug development and commercialisation services to pharmaceutical, biotechnology, medical device, and government organisations, today announced that its Accellacare Site Network has expanded in reach and capabilities through new partnership...

  4. Show article details.

    ICON plc to Present at the 30th Annual Credit Suisse Healthcare Conference and the 4th Annual Evercore ISI HealthCONx Conference

    Business Wire – 5:00 PM ET 11/05/2021

    ICON plc (ICLR), a world-leading healthcare intelligence and clinical research organisation, today announced that Mr. Brendan Brennan, CFO of ICON plc (ICLR), will present at: Any changes to these events and links to the live webcasts will be posted on the Investor section of our website under “Events”. About ICON plc (ICLR) ICON plc (ICLR) is a world-leading healthcare intelligence and clinical research organisation.

  5. Show article details.

    BRIEF-Icon PLC Reports Qtrly Adj Net Income Attributable To Group Was $2.55 Per Diluted Share

    Reuters – 6:42 PM ET 11/03/2021

    ICON PLC (ICLR): * QUARTER 3 ADJUSTED REVENUE OF $1,870.4 MILLION REPRESENTING A YEAR ON YEAR INCREASE OF 167%. * QTRLY ADJUSTED NET INCOME ATTRIBUTABLE TO GROUP WAS $2.55 PER DILUTED SHARE. * FULL YEAR 2021 REVENUE GUIDANCE ISSUED IN RANGE OF $5,430 - $5,530 MILLION.

  6. Show article details.

    ICON Reports Third Quarter 2021 Results

    Business Wire – 4:50 PM ET 11/03/2021

    Highlights  . DUBLIN---- ICON plc (ICLR), a world-leading healthcare intelligence and clinical research organisation, today reported its financial results for the third quarter ended September 30, 2021.

  7. Show article details.

    Tánaiste announces multi-million Euro R&D support of ICON to accelerate decentralised clinical trial technology

    Business Wire – 4:05 PM ET 09/22/2021

    ICON secures Enterprise Ireland funding to enhance digital health technology and data analytics solutions The Tánaiste and Minister for Enterprise, Trade and Employment, Leo Varadkar TD announced today that ICON plc (ICLR), a Dublin-based global provider of drug development and commercialisation services to pharmaceutical, biotechnology and medical device industries, has been awarded €4 million in R&D...

  8. Show article details.

    ICON plc to Present at the Wells Fargo 16th Annual Healthcare Conference and the Baird Global Healthcare Conference

    Business Wire – 6:00 AM ET 09/02/2021

    ICON plc (ICLR), a world-leading healthcare intelligence and clinical research organisation, today announced that Mr. Brendan Brennan, CFO of ICON plc (ICLR), will present at: Any changes to these events and links to the live webcasts will be posted on the Investor section of our website under “Events”. About ICON plc (ICLR) ICON plc (ICLR) is a world-leading healthcare intelligence and clinical research organisation.

Page:

Today's and Upcoming Events

  • Feb
    22

    ICLR to announce Q4 earnings (Unconfirmed)

Past Events (last 90 days)

  • Nov
    03

    ICLR announced Q3 earnings.

Data provided by Thomson Reuters © 2021

Technical Events

Technical Analysis

PROVIDED BY TRADING CENTRAL
As with all your investments through Fidelity, you must make your own determination whether an investment is appropriate for you. Fidelity is not recommending or endorsing this security by making it available to customers. You should conduct research and perform a thorough investigation as to the characteristics of any securities you intend to purchase. Before investing, you should read the prospectus, offering circular, indenture, or similar document carefully for a full description of the product, including its features and risks, to determine whether it is an appropriate investment for your investment objectives, risk tolerance, financial situation and other individual factors, and be sure to re-evaluate those factors on a periodic basis.

Performance data shown represents past performance, which is no guarantee of future results. Current performance may be higher or lower than the performance data quoted. Yield and return will vary, therefore, you may have a gain or loss when you sell your shares.


Stock markets are volatile and can decline significantly in response to adverse issuer, political, regulatory, market, or economic developments. Growth stocks can be more volatile than other types of stocks. Value stocks can continue to be undervalued by the market for long periods of time. Foreign securities are subject to interest-rate, currency-exchange-rate, economic, and political risks, all of which are magnified in emerging markets. Illiquidity is an inherent risk associated with investing in real estate and REITs. There is no guarantee the issuer of a REIT will maintain the secondary market for its shares and redemptions may be at a price which is more or less than the original price paid. Closed-end funds can trade at a discount to their NAV. Shareholders of Master Limited Partnerships may be treated as partners for tax purposes. Partnerships issue a Schedule K-1 (Form 1065) rather than a Form 1099 form for tax purposes. It lists the partner's share of income, deductions, credits, etc. Speak with your tax advisor to determine how this may affect you. A royalty trust is a type of corporation, mostly in the United States or Canada, usually involved in oil and gas production or mining. Royalty trusts may have special tax treatment, so you should consult a tax advisor on the potential tax consequences of investing in them.

News, commentary and events are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.

Any data, charts and other information provided on this page are intended for research purposes to help self-directed investors evaluate many types of securities including, but not limited to common stocks, American Depository Receipts, Master Limited Partnerships, real estate investment trusts. traditional preferred stock, trust preferred securities, third-party trust certificates, convertible securities, mandatory convertible securities and other exchange-traded equity and/or debt securities. Criteria and inputs entered, including the choice to make security comparisons, are at the sole discretion of the user and are solely for the convenience of the user. Analyst opinions, ratings and reports are provided by third-parties unaffiliated with Fidelity. All information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance, an offer of or a solicitation of an offer to buy or sell a security, or a recommendation or endorsement by Fidelity of any security or investment strategy. Fidelity does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from its use.

462499.6.0
See the Latest Features
Personalized
Get relevant information about your holdings right when you need it.
See Your Performance Click the portfolio icon to get information about stocks you own without leaving the research page.
Faster Access to Positions A shortcut to view the full list of positions in your portfolio? Yes, please! Use the ticker search box.
Add Your Own Notes Use Notebook to save your investment ideas in one convenient, private, and secure place.
Convenient For You
Research that's clear, accessible, and all in one place makes for a better experience.
One-Stop Shop See everything you need to make investment decisions right in the dashboard.
Access Anywhere No matter where you are, use the Stock Research experience across multiple devices.
New Ideas, On the Ready Find new ideas using quick links to the Stock Screener.
New Ways to Research
Discover new tools to add or diversify your existing research strategy.
StockTwits Read live tweets from the financial and investing community about the stock you're interested in.
Fundamental Analysis Save time on research by getting an overall assessment of a company's valuation, quality, growth stability, and financial health.
Recognia Technical Analysis Perfect for the technical trader—this indicator captures a stock's technical events and converts them into short, medium, and long-term sentiment.
Top Competitors See how a stock measures up by instantly comparing it to the industry average and its top four competitors.
Social Sentiment Get a sense of people's overall feelings towards a company in social media with this summary tool.
Earnings Data Monitor earnings expectations over the past three quarters and model a stock's price based on its P/E.